Trial Profile
ASKP1240 in De Novo Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2019
Price :
$35
*
At a glance
- Drugs Bleselumab (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 11 Sep 2019 Results published in the American Journal of Transplantation
- 10 Aug 2015 New trial record